{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:52:18Z","timestamp":1793699538075,"version":"4.5.1"},"reference-count":234,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Emerging infectious diseases (EIDs) are an increasing threat to public health on a global scale. In recent times, the most prominent outbreaks have constituted RNA viruses, spreading via droplets (COVID-19 and Influenza A H1N1), directly between humans (Ebola and Marburg), via arthropod vectors (Dengue, Zika, West Nile, Chikungunya, Crimean Congo) and zoonotically (Lassa fever, Nipah, Rift Valley fever, Hantaviruses). However, specific approved antiviral therapies and vaccine availability are scarce, and public health measures remain critical. Patients can present with a spectrum of ocular manifestations. Emerging infectious diseases should therefore be considered in the differential diagnosis of ocular inflammatory conditions in patients inhabiting or returning from endemic territories, and more general vigilance is advisable in the context of a global pandemic. Eye specialists are in a position to facilitate swift diagnosis, improve clinical outcomes, and contribute to wider public health efforts during outbreaks. This article reviews those emerging viral diseases associated with reports of ocular manifestations and summarizes details pertinent to practicing eye specialists.<\/jats:p>","DOI":"10.1038\/s41433-020-01376-y","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T13:26:09Z","timestamp":1611926769000},"page":"1117-1139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Ocular manifestations of emerging viral diseases"],"prefix":"10.1038","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0321-6750","authenticated-orcid":false,"given":"Ashwin","family":"Venkatesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3469-7868","authenticated-orcid":false,"given":"Ravi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8954-6920","authenticated-orcid":false,"given":"Simran","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8990-3059","authenticated-orcid":false,"given":"Timothy","family":"Rajaratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anant","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parwez","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"key":"1376_CR1","unstructured":"World Health Organization, Regional Office for South-East Asia. A brief guide to emerging infectious diseases and zoonoses. WHO Regional Office for South-East Asia; 2014."},{"key":"1376_CR2","unstructured":"G. P. M. Board, World Health Organization. A world at risk: annual report on global preparedness for health emergencies. Geneva: G. P. M. Board, World Health Organization; 2019."},{"key":"1376_CR3","first-page":"177","volume":"26","author":"S Sharma","year":"2012","unstructured":"Sharma S. Diagnosis of infectious diseases of the eye. Eye Lond Engl. 2012;26:177\u201384.","journal-title":"Eye Lond Engl"},{"key":"1376_CR4","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1097\/ICU.0000000000000426","volume":"28","author":"JG Shantha","year":"2017","unstructured":"Shantha JG, Crozier I, Yeh S. An update on ocular complications of Ebola virus disease. Curr Opin Ophthalmol. 2017;28:600\u20136.","journal-title":"Curr Opin Ophthalmol"},{"key":"1376_CR5","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1080\/09273948.2017.1294184","volume":"26","author":"R Agrawal","year":"2018","unstructured":"Agrawal R, Oo HH, Balne PK, Ng L, Tong L, Leo YS. Zika Virus and the Eye. Ocul Immunol Inflamm. 2018;26:654\u20139. https:\/\/doi.org\/10.1080\/09273948.2017.1294184.","journal-title":"Ocul Immunol Inflamm"},{"key":"1376_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s40123-012-0002-z","volume":"1","author":"VC Yip","year":"2012","unstructured":"Yip VC, Sanjay S, Koh YT. Ophthalmic complications of dengue fever: a systematic review. Ophthalmol Ther. 2012;1:2. https:\/\/doi.org\/10.1007\/s40123-012-0002-z.","journal-title":"Ophthalmol Ther"},{"key":"1376_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1001\/jamaophthalmol.2020.1291","volume":"138","author":"P Wu","year":"2020","unstructured":"Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138:575\u20138. https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.1291.","journal-title":"JAMA Ophthalmol."},{"key":"1376_CR8","unstructured":"World Health Organisation. Prioritizing diseases for research and development in emergency contexts. 2021. https:\/\/www.who.int\/activities\/prioritizing-diseases-for-research-and-development-in-emergency-contexts. Accessed 18 Jan 2021."},{"key":"1376_CR9","unstructured":"World Health Organisation. Ebola virus disease. 2020. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/ebola-virus-disease."},{"key":"1376_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-020-0147-3","volume":"6","author":"ST Jacob","year":"2020","unstructured":"Jacob ST, Crozier I, Fischer WA 2nd, Hewlett A, Kraft CS, Vega MA, et al. Ebola virus disease. Nat Rev Dis Primers. 2020;6:13. https:\/\/doi.org\/10.1038\/s41572-020-0147-3.","journal-title":"Nat Rev Dis Primers"},{"key":"1376_CR11","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1093\/cid\/ciw158","volume":"62","author":"A Tiffany","year":"2016","unstructured":"Tiffany A, Vetter P, Mattia J, Dayer JA, Bartsch M, Kasztura M, et al. Ebola virus disease complications as experienced by survivors in Sierra Leone. Clin Infect Dis. 2016;62:1360\u20136. https:\/\/doi.org\/10.1093\/cid\/ciw158.","journal-title":"Clin Infect Dis"},{"key":"1376_CR12","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1080\/09273948.2018.1484493","volume":"26","author":"S Yeh","year":"2018","unstructured":"Yeh S, Shantha JG, Hayek B, Crozier I, Smith JR. Clinical manifestations and pathogenesis of Uveitis in Ebola virus disease survivors. Ocul Immunol Inflamm. 2018;26:1128\u201334.","journal-title":"Ocul Immunol Inflamm"},{"issue":"Suppl 1","key":"1376_CR13","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1086\/514288","volume":"179","author":"K Kibadi","year":"1999","unstructured":"Kibadi K, Mupapa K, Kuvula K, Massamba M, Ndaberey D, Muyembe-Tamfum JJ, et al. Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo. J Infect Dis. 1999;179(Suppl 1):S13\u20134. https:\/\/doi.org\/10.1086\/514288.","journal-title":"J Infect Dis."},{"key":"1376_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1473-3099(15)00489-2","volume":"16","author":"JG Mattia","year":"2016","unstructured":"Mattia JG, Vandy MJ, Chang JC, Platt DE, Dierberg K, Bausch DG, et al. Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study. Lancet Infect Dis. 2016;16:331\u20138. https:\/\/doi.org\/10.1016\/S1473-3099(15)00489-2.","journal-title":"Lancet Infect Dis."},{"key":"1376_CR15","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ajo.2016.12.005","volume":"175","author":"E Hereth-Hebert","year":"2017","unstructured":"Hereth-Hebert E, Bah MO, Etard JF, Sow MS, Resnikoff S, Fardeau C, et al. Ocular complications in survivors of the Ebola outbreak in Guinea. Am J Ophthalmol. 2017;175:114\u201321. https:\/\/doi.org\/10.1016\/j.ajo.2016.12.005.","journal-title":"Am J Ophthalmol"},{"key":"1376_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ophtha.2016.10.011","volume":"124","author":"JG Shantha","year":"2017","unstructured":"Shantha JG, Crozier I, Hayek BR, Bruce BB, Gargu C, Brown J, et al. Ophthalmic Manifestations and causes of vision impairment in Ebola virus disease survivors in Monrovia, Liberia. Ophthalmology. 2017;124:170\u20137. https:\/\/doi.org\/10.1016\/j.ophtha.2016.10.011.","journal-title":"Ophthalmology."},{"key":"1376_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3201\/eid2202.151416","volume":"22","author":"JR Chancellor","year":"2016","unstructured":"Chancellor JR, Padmanabhan SP, Greenough TC, Sacra R, Ellison RT 3rd, Madoff LC, et al. Uveitis and systemic inflammatory markers in convalescent phase of Ebola virus disease. Emerg Infect Dis. 2016;22:295\u20137. https:\/\/doi.org\/10.3201\/eid2202.151416.","journal-title":"Emerg Infect Dis"},{"key":"1376_CR18","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1001\/jamaophthalmol.2018.1248","volume":"136","author":"PJ Steptoe","year":"2018","unstructured":"Steptoe PJ, Momorie F, Fornah AD, Komba SP, Emsley E, Scott JT, et al. Multimodal imaging and spatial analysis of ebola retinal lesions in 14 survivors of Ebola virus disease. JAMA Ophthalmol. 2018;136:689\u201393. https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.1248.","journal-title":"JAMA Ophthalmol"},{"key":"1376_CR19","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1056\/NEJMoa1805435","volume":"380","author":"MC Sneller","year":"2019","unstructured":"REVAIL III Study Group, Sneller MC, Reilly C, Badio M, Bishop RJ, Eghrari AO, et al. A longitudinal study of Ebola Sequelae in Liberia. N Engl J Med. 2019;380:924\u201334. https:\/\/doi.org\/10.1056\/NEJMoa1805435.","journal-title":"N Engl J Med"},{"key":"1376_CR20","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1056\/NEJMoa1500306","volume":"372","author":"JB Varkey","year":"2015","unstructured":"Varkey JB, Shantha JG, Crozier I, Kraft CS, Lyon GM, Mehta AK, et al. Persistence of Ebola virus in ocular fluid during convalescence. N Engl J Med. 2015;372:2423\u20137. https:\/\/doi.org\/10.1056\/NEJMoa1500306.","journal-title":"N Engl J Med"},{"key":"1376_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ebiom.2018.03.020","volume":"30","author":"JG Shantha","year":"2018","unstructured":"Shantha JG, Mattia JG, Goba A, Barnes KG, Ebrahim FK, Kraft CS, et al. Ebola virus persistence in ocular tissues and fluids (EVICT) study: reverse transcription-polymerase chain reaction and cataract surgery outcomes of Ebola survivors in Sierra Leone. EBioMedicine. 2018;30:217\u201324. https:\/\/doi.org\/10.1016\/j.ebiom.2018.03.020.","journal-title":"EBioMedicine."},{"key":"1376_CR22","doi-asserted-by":"publisher","first-page":"e0007209","DOI":"10.1371\/journal.pntd.0007209","volume":"13","author":"JG Shantha","year":"2019","unstructured":"Shantha JG, Hayek BR, Crozier I, Gargu C, Dolo R, Brown J, et al. Development of a screening eye clinic for Ebola virus disease survivors: lessons learned and rapid implementation at ELWA Hospital in Monrovia, Liberia 2015. PLoS Negl Trop Dis. 2019;13:e0007209. https:\/\/doi.org\/10.1371\/journal.pntd.0007209.","journal-title":"PLoS Negl Trop Dis"},{"key":"1376_CR23","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","volume":"381","author":"S Mulangu","year":"2019","unstructured":"Mulangu S, Dodd LE, Davey RT Jr, Tshiani Mbaya O, Proschan M, Mukadi D, et al. A randomized, controlled trial of Ebola virus disease therapeutics. N Engl J Med. 2019;381:2293\u2013303. https:\/\/doi.org\/10.1056\/NEJMoa1910993.","journal-title":"N Engl J Med"},{"key":"1376_CR24","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","volume":"386","author":"AM Henao-Restrepo","year":"2015","unstructured":"Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A, et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet. 2015;386:857\u201366. https:\/\/doi.org\/10.1016\/S0140-6736(15)61117-5.","journal-title":"Lancet."},{"key":"1376_CR25","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/trstmh\/trv024","volume":"109","author":"DM Pigott","year":"2015","unstructured":"Pigott DM, Golding N, Mylne A, Huang Z, Weiss DJ, Brady OJ, et al. Mapping the zoonotic niche of Marburg virus disease in Africa. Trans R Soc Trop Med Hyg. 2015;109:366\u201378. https:\/\/doi.org\/10.1093\/trstmh\/trv024.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1376_CR26","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/ije\/dyv307","volume":"45","author":"J Brainard","year":"2016","unstructured":"Brainard J, Hooper L, Pond K, Edmunds K, Hunter PR. Risk factors for transmission of Ebola or Marburg virus disease: a systematic review and meta-analysis. Int J Epidemiol. 2016;45:102\u201316.","journal-title":"Int J Epidemiol"},{"key":"1376_CR27","unstructured":"World Health Organisation. Marburg virus disease. 2018. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/marburg-virus-disease."},{"key":"1376_CR28","unstructured":"CDC. Marburg Hemorrhagic Fever (Marburg HF) | CDC; 2019. https:\/\/www.cdc.gov\/vhf\/marburg\/index.html."},{"key":"1376_CR29","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1136\/bmj.4.5995.489","volume":"4","author":"JS Gear","year":"1975","unstructured":"Gear JS, Cassel GA, Gear AJ, Trappler B, Clausen L, Meyers AM, et al. Outbreake of Marburg virus disease in Johannesburg. Br Med J. 1975;4:489\u201393. https:\/\/doi.org\/10.1136\/bmj.4.5995.489.","journal-title":"Br Med J"},{"key":"1376_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/bjo.61.4.265","volume":"61","author":"BS Kuming","year":"1977","unstructured":"Kuming BS, Kokoris N. Uveal involvement in Marburg virus disease. Br J Ophthalmol. 1977;61:265\u20136.","journal-title":"Br J Ophthalmol"},{"issue":"suppl_5","key":"1376_CR31","doi-asserted-by":"publisher","first-page":"S423","DOI":"10.1093\/infdis\/jiy367","volume":"218","author":"TK Cooper","year":"2018","unstructured":"Cooper TK, Sword J, Johnson JC, Bonilla A, Hart R, Liu DX, et al. New insights into Marburg virus disease pathogenesis in the Rhesus Macaque model. J Infect Dis. 2018;218(suppl_5):S423\u201333. https:\/\/doi.org\/10.1093\/infdis\/jiy367.","journal-title":"J Infect Dis."},{"key":"1376_CR32","unstructured":"BMJ Best Practice. Marburg virus infection\u2014symptoms, diagnosis and treatment. https:\/\/bestpractice.bmj.com\/topics\/en-gb\/1615."},{"key":"1376_CR33","unstructured":"Ebola and Marburg virus disease epidemics: preparedness, alert, control, and evaluation. Interim manual version 1.2 World Health Organization. WHO reference number: WHO\/HSE\/PED\/CED\/2014.05 August 2014. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/130160\/WHO_HSE_PED_CED_2014.05_eng.pdf?sequence=1."},{"key":"1376_CR34","doi-asserted-by":"publisher","first-page":"5922","DOI":"10.1073\/pnas.88.13.5922","volume":"88","author":"EC Schirmer","year":"1991","unstructured":"Schirmer EC, Wyatt LS, Yamanishi K, Rodriguez WJ, Frenkel N. Differentiation between two distinct classes of viruses now classified as human herpesvirus 6. Proc Natl Acad Sci USA. 1991;88:5922\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1376_CR35","doi-asserted-by":"publisher","unstructured":"Campadelli-Fiume G, Mirandola P, Menotti L. Human herpesvirus 6: an emerging pathogen. Emerg Infect Dis J. 1999;5. https:\/\/doi.org\/10.3201\/eid0503.990306.","DOI":"10.3201\/eid0503.990306"},{"key":"1376_CR36","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1167\/iovs.12-10095","volume":"53","author":"S Sugita","year":"2012","unstructured":"Sugita S, Shimizu N, Watanabe K, Ogawa M, Maruyama K, Usui N, et al. Virological analysis in patients with human herpes virus 6-associated ocular inflammatory disorders. Investig Ophthalmol Vis Sci. 2012;53:4692\u20138. https:\/\/doi.org\/10.1167\/iovs.12-10095.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1376_CR37","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/s0140.6736(88)91893-4","volume":"1","author":"K Yamanishi","year":"1988","unstructured":"Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet. 1988;1:1065\u20137. https:\/\/doi.org\/10.1016\/s0140.6736(88)91893-4.","journal-title":"Lancet."},{"key":"1376_CR38","first-page":"527","volume":"8","author":"HB Qavi","year":"1994","unstructured":"Qavi HB, Green MT, Pearson G, Ablashi D. Possible role of HHV-6 in the development of AIDS retinitis. Vivo Athens Greece. 1994;8:527\u201332.","journal-title":"Vivo Athens Greece"},{"key":"1376_CR39","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/s0002-9394(14)71814-8","volume":"114","author":"I Reux","year":"1992","unstructured":"Reux I, Fillet AM, Agut H, Katlama C, Hauw JJ, LeHoang P. In situ detection of human herpesvirus 6 in retinitis associated with acquired immunodeficiency syndrome. Am J Ophthalmol. 1992;114:375\u20137. https:\/\/doi.org\/10.1016\/s0002-9394(14)71814-8.","journal-title":"Am J Ophthalmol"},{"key":"1376_CR40","first-page":"2759","volume":"33","author":"HB Qavi","year":"1992","unstructured":"Qavi HB, Green MT, SeGall GK, Lewis DE, Hollinger FB. Transcriptional activity of HIV-1 and HHV-6 in retinal lesions from AIDS patients. Invest Ophthalmol Vis Sci. 1992;33:2759\u201367.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1376_CR41","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/(SICI)1096-9071(199608)49:4<289::AID-JMV6>3.0.CO;2-#","volume":"49","author":"AM Fillet","year":"1996","unstructured":"Fillet AM, Reux I, Joberty C, Fournier JG, Hauw JJ, Le Hoang P, et al. Detection of human herpes virus 6 in AIDS-associated retinitis by means of in situ hybridization, polymerase chain reaction and immunohistochemistry. J Med Virol. 1996;49:289\u201395. https:\/\/doi.org\/10.1002\/(SICI)1096-9071(199608)49:4<289::AID-JMV6>3.0.CO;2-#.","journal-title":"J Med Virol"},{"key":"1376_CR42","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.ajo.2010.05.015","volume":"150","author":"JD de Groot-Mijnes","year":"2010","unstructured":"de Groot-Mijnes JD, de Visser L, Zuurveen S, Martinus RA, V\u00f6lker R, ten Dam-van Loon NH, et al. Identification of new pathogens in the intraocular fluid of patients with uveitis. Am J Ophthalmol. 2010;150:628\u201336. https:\/\/doi.org\/10.1016\/j.ajo.2010.05.015.","journal-title":"Am J Ophthalmol"},{"key":"1376_CR43","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/jmv.21751","volume":"82","author":"JI Cohen","year":"2010","unstructured":"Cohen JI, Fahle G, Kemp MA, Apakupakul K, Margolis TP. Human herpesvirus 6-A, 6-B, and 7 in vitreous fluid samples. J Med Virol. 2010;82:996\u20139.","journal-title":"J Med Virol"},{"key":"1376_CR44","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1001\/archopht.125.10.1426","volume":"125","author":"S Sugita","year":"2007","unstructured":"Sugita S, Shimizu N, Kawaguchi T, Akao N, Morio T, Mochizuki M. Identification of human herpesvirus 6 in a patient with severe unilateral panuveitis. Arch Ophthalmol. 2007;125:1426\u20137. https:\/\/doi.org\/10.1001\/archopht.125.10.1426.","journal-title":"Arch Ophthalmol"},{"key":"1376_CR45","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1016\/j.jinf.2006.12.012","volume":"54","author":"J Maslin","year":"2007","unstructured":"Maslin J, Bigaillon C, Froussard F, Enouf V, Nicand E. Acute bilateral uveitis associated with an active human herpesvirus-6 infection. J Infect. 2007;54:e237\u201340.","journal-title":"J Infect"},{"key":"1376_CR46","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s10384-011-0069-4","volume":"55","author":"N Ogata","year":"2011","unstructured":"Ogata N, Koike N, Yoshikawa T, Takahashi K. Human herpesvirus 6-associated uveitis with optic neuritis diagnosed by multiplex PCR. Jpn J Ophthalmol. 2011;55:502\u20135.","journal-title":"Jpn J Ophthalmol"},{"key":"1376_CR47","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/jmv.20833","volume":"79","author":"F M\u00e9cha\u00ef","year":"2007","unstructured":"M\u00e9cha\u00ef F, Boutolleau D, Manceron V, Gasnault J, Quertainmont Y, Brosseau JP, et al. Human herpesvirus 6-associated retrobulbar optic neuritis in an HIV-infected patient: response to anti-herpesvirus therapy and long-term outcome. J Med Virol. 2007;79:931\u20134. https:\/\/doi.org\/10.1002\/jmv.20833.","journal-title":"J Med Virol"},{"key":"1376_CR48","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jcv.2006.08.018","volume":"37","author":"D Moschettini","year":"2006","unstructured":"Moschettini D, Franceschini R, Vaccaro NM, Cermelli C, Pezzini F, Balestrieri M, et al. Human herpesvirus-6B active infection associated with relapsing bilateral anterior optic neuritis. J Clin Virol. 2006;37:244\u20137. https:\/\/doi.org\/10.1016\/j.jcv.2006.08.018.","journal-title":"J Clin Virol"},{"key":"1376_CR49","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/bjh.13826","volume":"172","author":"Y Hino","year":"2016","unstructured":"Hino Y, Doki N, Sekiya N, Takaki Y, Ohashi K. Optic neuritis as an initial manifestation of human herpesvirus 6 reactivation after unrelated bone marrow transplantation. Br J Haematol. 2016;172:654.","journal-title":"Br J Haematol"},{"key":"1376_CR50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/(SICI)1096-9071(199710)53:2<105::AID-JMV1>3.0.CO;2-D","volume":"53","author":"Y Arao","year":"1997","unstructured":"Arao Y, Soushi S, Sato Y, Moriishi E, Ando Y, Yamada M, et al. Infection of a human retinal pigment epithelial cell line with human herpesvirus 6 variant A. J Med Virol. 1997;53:105\u201310.","journal-title":"J Med Virol"},{"key":"1376_CR51","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1086\/315391","volume":"181","author":"A Humar","year":"2000","unstructured":"Humar A, Malkan G, Moussa G, Greig P, Levy G, Mazzulli T. Human herpesvirus-6is associated with cytomegalovirus reactivation in liver transplant recipients. J Infect Dis. 2000;181:1450\u20133. https:\/\/doi.org\/10.1086\/315391.","journal-title":"J Infect Dis"},{"key":"1376_CR52","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/ICO.0b013e3181e2e9be","volume":"30","author":"T Okuno","year":"2011","unstructured":"Okuno T, Hooper LC, Ursea R, Smith J, Nussenblatt R, Hooks JJ, et al. Role of human herpes virus 6 in corneal inflammation alone or with human herpesviruses. Cornea. 2011;30:204\u20137. https:\/\/doi.org\/10.1097\/ICO.0b013e3181e2e9be.","journal-title":"Cornea."},{"key":"1376_CR53","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1097\/ICL.0b013e3182a70a1b","volume":"41","author":"A Boto-de-los-Bueis","year":"2015","unstructured":"Boto-de-los-Bueis A, Romero G\u00f3mez MP, del Hierro Zarzuelo A, Sanchez EG, Mediero S, Noval S. Recurrent ocular surface inflammation associated with human herpesvirus 6 infection. Eye Contact Lens. 2015;41:e11\u20133. https:\/\/doi.org\/10.1097\/ICL.0b013e3182a70a1b.","journal-title":"Eye Contact Lens"},{"key":"1376_CR54","unstructured":"HHV-6 Foundation. HHV-6A\/B testing overview on testing for HHV-6 infection. 2021. https:\/\/hhv-6foundation.org\/patients\/hhv-6-testing-for-patients."},{"issue":"Suppl 2","key":"1376_CR55","first-page":"105A","volume":"11","author":"S Dewhurst","year":"2004","unstructured":"Dewhurst S. Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system. Herpes J IHMF. 2004;11 Suppl 2:105A\u201311A.","journal-title":"Herpes J IHMF"},{"key":"1376_CR56","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1128\/CMR.18.1.217-245.2005","volume":"18","author":"L De Bolle","year":"2005","unstructured":"De Bolle L, Naesens L, De Clercq E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev. 2005;18:217\u201345.","journal-title":"Clin Microbiol Rev"},{"key":"1376_CR57","unstructured":"World Health Organisation. Lassa fever. 2017. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/lassa-fever."},{"key":"1376_CR58","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/0035-9203(72)90269-6","volume":"66","author":"HA White","year":"1972","unstructured":"White HA. Lassa fever. A study of 23 hospital cases. Trans R Soc Trop Med Hyg. 1972;66:390\u2013401.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1376_CR59","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/infdis\/155.3.445","volume":"155","author":"JB McCormick","year":"1987","unstructured":"McCormick JB, King IJ, Webb PA, Johnson KM, O'Sullivan R, Smith ES, et al. A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis. 1987;155:445\u201355. https:\/\/doi.org\/10.1093\/infdis\/155.3.445.","journal-title":"J Infect Dis"},{"key":"1376_CR60","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/infdis\/141.5.580","volume":"141","author":"PB Jahrling","year":"1980","unstructured":"Jahrling PB, Hesse RA, Eddy GA, Johnson KM, Callis RT, Stephen EL. Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. J Infect Dis. 1980;141:580\u20139. https:\/\/doi.org\/10.1093\/infdis\/141.5.580.","journal-title":"J Infect Dis"},{"key":"1376_CR61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ijid.2019.07.015","volume":"87","author":"KA Eberhardt","year":"2019","unstructured":"Eberhardt KA, Mischlinger J, Jordan S, Groger M, G\u00fcnther S, Ramharter M. Ribavirin for the treatment of Lassa fever: a systematic review and meta-analysis. Int J Infect Dis. 2019;87:15\u201320. https:\/\/doi.org\/10.1016\/j.ijid.2019.07.015.","journal-title":"Int J Infect Dis"},{"key":"1376_CR62","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJM198601023140104","volume":"314","author":"JB McCormick","year":"1986","unstructured":"McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med. 1986;314:20\u20136. https:\/\/doi.org\/10.1056\/NEJM198601023140104.","journal-title":"N Engl J Med"},{"key":"1376_CR63","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.antiviral.2013.07.011","volume":"100","author":"SP Luby","year":"2013","unstructured":"Luby SP. The pandemic potential of Nipah virus. Antivir Res. 2013;100:38\u201343.","journal-title":"Antivir Res"},{"key":"1376_CR64","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1136\/jnnp.74.1.131","volume":"74","author":"CC Lim","year":"2003","unstructured":"Lim CC, Lee WL, Leo YS, Lee KE, Chan KP, Ling AE, et al. Late clinical and magnetic resonance imaging follow up of Nipah virus infection. J Neurol Neurosurg Psychiatry. 2003;74:131\u20133. https:\/\/doi.org\/10.1136\/jnnp.74.1.131.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1376_CR65","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1056\/NEJM200004273421701","volume":"342","author":"KJ Goh","year":"2000","unstructured":"Goh KJ, Tan CT, Chew NK, Tan PS, Kamarulzaman A, Sarji SA, et al. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med. 2000;342:1229\u201335. https:\/\/doi.org\/10.1056\/NEJM200004273421701.","journal-title":"N Engl J Med"},{"key":"1376_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/srep30916","volume":"6","author":"CE Mire","year":"2016","unstructured":"Mire CE, Satterfield BA, Geisbert JB, Agans KN, Borisevich V, Yan L, et al. Pathogenic differences between Nipah virus Bangladesh and Malaysia strains in primates: implications for antibody therapy. Sci Rep. 2016;6:30916. https:\/\/doi.org\/10.1038\/srep30916.","journal-title":"Sci Rep"},{"key":"1376_CR67","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/01652176.2019.1580827","volume":"39","author":"RK Singh","year":"2019","unstructured":"Singh RK, Dhama K, Chakraborty S, Tiwari R, Natesan S, Khandia R, et al. Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies\u2014a comprehensive review. Vet Q. 2019;39:26\u201355. https:\/\/doi.org\/10.1080\/01652176.2019.1580827.","journal-title":"Vet Q"},{"key":"1376_CR68","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1017\/s0317167100001785","volume":"29","author":"HT Chong","year":"2002","unstructured":"Chong HT, Kunjapan SR, Thayaparan T, Tong J, Petharunam V, Jusoh MR, et al. Nipah encephalitis outbreak in Malaysia, clinical features in patients from Seremban. Can J Neurol Sci. 2002;29:83\u20137. https:\/\/doi.org\/10.1017\/s0317167100001785.","journal-title":"Can J Neurol Sci"},{"key":"1376_CR69","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.antiviral.2012.06.001","volume":"95","author":"T Ikegami","year":"2012","unstructured":"Ikegami T. Molecular biology and genetic diversity of Rift Valley fever virus. Antivir Res. 2012;95:293\u2013310.","journal-title":"Antivir Res"},{"key":"1376_CR70","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-ento-010715-023819","volume":"61","author":"KJ Linthicum","year":"2016","unstructured":"Linthicum KJ, Britch SC, Anyamba A. Rift Valley fever: an emerging mosquito-borne disease. Annu Rev Entomol. 2016;61:395\u2013415.","journal-title":"Annu Rev Entomol"},{"key":"1376_CR71","unstructured":"World Health Organisation. Rift Valley fever. 2018. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/rift-valley-fever."},{"key":"1376_CR72","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3201\/eid1902.120941","volume":"19","author":"O Dar","year":"2013","unstructured":"Dar O, McIntyre S, Hogarth S, Heymann D. Rift Valley fever and a new paradigm of research and development for zoonotic disease control. Emerg Infect Dis. 2013;19:189\u201393.","journal-title":"Emerg Infect Dis"},{"key":"1376_CR73","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cll.2017.01.004","volume":"37","author":"A Hartman","year":"2017","unstructured":"Hartman A. Rift Valley fever. Clin Lab Med. 2017;37:285\u2013301.","journal-title":"Clin Lab Med"},{"key":"1376_CR74","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1086\/345671","volume":"36","author":"M Al-Hazmi","year":"2003","unstructured":"Al-Hazmi M, Ayoola EA, Abdurahman M, Banzal S, Ashraf J, El-Bushra A, et al. Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans. Clin Infect Dis. 2003;36:245\u201352. https:\/\/doi.org\/10.1086\/345671.","journal-title":"Clin Infect Dis"},{"key":"1376_CR75","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ophtha.2004.09.018","volume":"112","author":"A Al-Hazmi","year":"2005","unstructured":"Al-Hazmi A, Al-Rajhi AA, Abboud EB, Ayoola EA, Al-Hazmi M, Saadi R, et al. Ocular complications of Rift Valley fever outbreak in Saudi Arabia. Ophthalmology. 2005;112:313\u20138. https:\/\/doi.org\/10.1016\/j.ophtha.2004.09.018.","journal-title":"Ophthalmology."},{"key":"1376_CR76","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/bjo.64.5.366","volume":"64","author":"AL Siam","year":"1980","unstructured":"Siam AL, Meegan JM, Gharbawi KF. Rift Valley fever ocular manifestations: observations during the 1977 epidemic in Egypt. Br J Ophthalmol 1980;64:366\u201374.","journal-title":"Br J Ophthalmol"},{"key":"1376_CR77","doi-asserted-by":"publisher","first-page":"e1265","DOI":"10.1371\/journal.pntd.0001265","volume":"5","author":"AD LaBeaud","year":"2011","unstructured":"LaBeaud AD, Muiruri S, Sutherland LJ, Dahir S, Gildengorin G, Morrill J, et al. Postepidemic analysis of Rift Valley fever virus transmission in northeastern Kenya: a village cohort study. PLoS Negl Trop Dis. 2011;5:e1265. https:\/\/doi.org\/10.1371\/journal.pntd.0001265.","journal-title":"PLoS Negl Trop Dis"},{"key":"1376_CR78","first-page":"908","volume":"25","author":"J Gear","year":"1951","unstructured":"Gear J, De Meillon B, Measroch V, Davis DHS, Harwin H. Rift Valley fever in South Africa. 2. The occurrence of human cases in the Orange Free State, the North-Western Cape Province, the Western and Southern Transvaal. B. Field and laboratory investigation. S Afr Med J Suid-Afr Tydskr Vir Geneeskd. 1951;25:908\u201312.","journal-title":"S Afr Med J Suid-Afr Tydskr Vir Geneeskd"},{"key":"1376_CR79","first-page":"930","volume":"25","author":"I Freed","year":"1951","unstructured":"Freed I. Rift Valley fever in man, complicated by retinal changes and loss of vision. S Afr Med J Suid-Afr Tydskr Vir Geneeskd. 1951;25:930\u20132.","journal-title":"S Afr Med J Suid-Afr Tydskr Vir Geneeskd"},{"key":"1376_CR80","unstructured":"Meegan JM, Watten RH, Laughlin LW. Clinical experience with Rift Valley fever in humans during the 1977 Egyptian epizootic. Proc. Rift Val. Fever Workshop. 1981."},{"key":"1376_CR81","first-page":"125","volume":"71","author":"M Ayoub","year":"1978","unstructured":"Ayoub M, Barhoma G, Zaghlol I. Ocular manifestations of Rift Valley fever. Bull Ophthalmol Soc Egypt. 1978;71:125\u201333.","journal-title":"Bull Ophthalmol Soc Egypt"},{"key":"1376_CR82","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0002-9394(14)75905-7","volume":"92","author":"AF Deutman","year":"1981","unstructured":"Deutman AF, Klomp HJ. Rift Valley fever retinitis. Am J Ophthalmol. 1981;92:38\u201342.","journal-title":"Am J Ophthalmol"},{"key":"1376_CR83","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12941-020-0346-5","volume":"19","author":"E Javelle","year":"2020","unstructured":"Javelle E, Lesueur A, Pommier de Santi V, de Laval F, Lefebvre T, Holweck G, et al. The challenging management of Rift Valley fever in humans: literature review of the clinical disease and algorithm proposal. Ann Clin Microbiol Antimicrob. 2020;19:4. https:\/\/doi.org\/10.1186\/s12941-020-0346-5.","journal-title":"Ann Clin Microbiol Antimicrob."},{"key":"1376_CR84","first-page":"709","volume":"56","author":"D Enr\u00eda","year":"1996","unstructured":"Enr\u00eda D, Padula P, Segura EL, Pini N, Edelstein A, Posse CR, et al. Hantavirus pulmonary syndrome in Argentina. Possibility of person to person transmission. Medicina. 1996;56:709\u201311.","journal-title":"Medicina."},{"key":"1376_CR85","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3201\/eid0302.970210","volume":"3","author":"RM Wells","year":"1997","unstructured":"Wells RM, Sosa Estani S, Yadon ZE, Enria D, Padula P, Pini N, et al. An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Hantavirus Pulmonary Syndrome Study Group for Patagonia. Emerg Infect Dis. 1997;3:171\u20134. https:\/\/doi.org\/10.3201\/eid0302.970210.","journal-title":"Emerg Infect Dis"},{"key":"1376_CR86","doi-asserted-by":"publisher","first-page":"685","DOI":"10.4161\/hv.7.6.15197","volume":"7","author":"DH Kr\u00fcger","year":"2011","unstructured":"Kr\u00fcger DH, Sch\u00f6nrich G, Klempa B. Human pathogenic hantaviruses and prevention of infection. Hum Vaccin. 2011;7:685\u201393.","journal-title":"Hum Vaccin"},{"key":"1376_CR87","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s12250-016-3899-","volume":"32","author":"H Jiang","year":"2017","unstructured":"Jiang H, Zheng X, Wang L, Du H, Wang P, Bai X. Hantavirus infection: a global zoonotic challenge. Virol Sin. 2017;32:32\u201343. https:\/\/doi.org\/10.1007\/s12250-016-3899-x.","journal-title":"Virol Sin."},{"key":"1376_CR88","first-page":"e6","volume":"21S","author":"T Av\u0161i\u010d-\u017dupanc","year":"2019","unstructured":"Av\u0161i\u010d-\u017dupanc T, Saksida A, Korva M. Hantavirus infections. Clin Microbiol Infect Publ Eur Soc Clin Microbiol Infect Dis. 2019;21S:e6\u2013e16.","journal-title":"Clin Microbiol Infect Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"1376_CR89","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1136\/bjo.78.12.903","volume":"78","author":"M Kontkanen","year":"1994","unstructured":"Kontkanen M, Puustj\u00e4rvi T, L\u00e4hdevirta J. Myopic shift and its mechanism in nephropathia epidemica or Puumala virus infection. Br J Ophthalmol. 1994;78:903\u20136.","journal-title":"Br J Ophthalmol"},{"key":"1376_CR90","doi-asserted-by":"publisher","first-page":"E435","DOI":"10.1111\/j.1469-0691.2012.03997.x","volume":"18","author":"G Theiler","year":"2012","unstructured":"Theiler G, Langer-Wegscheider B, Zollner-Schwetz I, Valentin T, H\u00f6nigl M, Schnedl W, et al. Blurred vision and myopic shift in Puumala virus infections are independent of disease severity. Clin Microbiol Infect. 2012;18:E435\u20137. https:\/\/doi.org\/10.1111\/j.1469-0691.2012.03997.x.","journal-title":"Clin Microbiol Infect"},{"key":"1376_CR91","first-page":"425","volume":"73","author":"C Tilkin","year":"2018","unstructured":"Tilkin C, Bonnet S. [Acute myopic shift call sign of hantavirus infection]. Rev Med Liege. 2018;73:425\u20137.","journal-title":"Rev Med Liege"},{"key":"1376_CR92","doi-asserted-by":"publisher","unstructured":"Baillieul A, Le TL, Rouland J-F. Acute angle-closure glaucoma with choroidal effusion revealing a hantavirus infection: description of ultrasound biomicroscopy imagery and optical coherence tomography Visante. Eur J Ophthalmol. 2019. https:\/\/doi.org\/10.1177\/1120672119858895.","DOI":"10.1177\/1120672119858895"},{"key":"1376_CR93","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1136\/bjo.2010.185413","volume":"95","author":"N Hautala","year":"2011","unstructured":"Hautala N, Kauma H, Vapalahti O, M\u00e4h\u00f6nen SM, Vainio O, Vaheri A, et al. Prospective study on ocular findings in acute Puumala hantavirus infection in hospitalised patients. Br J Ophthalmol. 2011;95:559\u201362. https:\/\/doi.org\/10.1136\/bjo.2010.185413.","journal-title":"Br J Ophthalmol"},{"key":"1376_CR94","doi-asserted-by":"publisher","first-page":"378","DOI":"10.4103\/0301-4738.33827","volume":"55","author":"S Mehta","year":"2007","unstructured":"Mehta S, Jiandani P. Ocular features of hantavirus infection. Indian J Ophthalmol. 2007;55:378\u201380.","journal-title":"Indian J Ophthalmol"},{"key":"1376_CR95","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1016\/j.jcjo.2016.09.017","volume":"52","author":"Y Cao","year":"2017","unstructured":"Cao Y, Zhao X, Yi J, Tang R, Lei S. Hantavirus retinitis and concurrent hemorrhagic fever with renal syndrome. Can J Ophthalmol. 2017;52:e41\u20134.","journal-title":"Can J Ophthalmol"},{"key":"1376_CR96","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.3389\/fmicb.2019.02989","volume":"10","author":"R Liu","year":"2020","unstructured":"Liu R, Ma H, Shu J, Zhang Q, Han M, Liu Z, et al. Vaccines and therapeutics against hantaviruses. Front Microbiol. 2020;10:2989. https:\/\/doi.org\/10.3389\/fmicb.2019.02989.","journal-title":"Front Microbiol"},{"key":"1376_CR97","first-page":"1","volume":"2","author":"MG Guzman","year":"2016","unstructured":"Guzman MG, Gubler DJ, Izquierdo A, Martinez E, Halstead SB. Dengue infection. Nat Rev Dis Prim. 2016;2:1\u201325.","journal-title":"Nat Rev Dis Prim"},{"key":"1376_CR98","unstructured":"Organization, WH. Dengue guidelines for diagnosis, treatment, prevention and control: new edition. World Health Organization; 2009."},{"key":"1376_CR99","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496:504\u20137. https:\/\/doi.org\/10.1038\/nature12060.","journal-title":"Nature."},{"key":"1376_CR100","unstructured":"Beatty M, Letson G, Margolis HS. Estimating the global burden of dengue. Am J Trop Med Hyg. 2009;81."},{"key":"1376_CR101","unstructured":"World Health Organization. Global strategy for dengue prevention and control 2012\u20132020. https:\/\/apps.who.int\/iris\/handle\/10665\/75303."},{"key":"1376_CR102","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2149\/tmh.2011-S05","volume":"39","author":"DJ Gubler","year":"2011","unstructured":"Gubler DJ. Dengue, urbanization and globalization: the unholy trinity of the 21st century. Trop Med Health. 2011;39:3\u201311.","journal-title":"Trop Med Health"},{"key":"1376_CR103","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3129\/i06-069","volume":"41","author":"HK Kapoor","year":"2006","unstructured":"Kapoor HK, Bhai S, John M, Xavier J. Ocular manifestations of dengue fever in an East Indian epidemic. Can J Ophthalmol. 2006;41:741\u20136.","journal-title":"Can J Ophthalmol"},{"key":"1376_CR104","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/eye.2008.124","volume":"23","author":"A Gupta","year":"2009","unstructured":"Gupta A, Srinivasan R, Setia S, Soundravally R, Pandian DG. Uveitis following dengue fever. Eye. 2009;23:873\u20136.","journal-title":"Eye"},{"key":"1376_CR105","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/ICU.0000000000000613","volume":"30","author":"T Somkijrungroj","year":"2019","unstructured":"Somkijrungroj T, Kongwattananon W. Ocular manifestations of dengue. Curr Opin Ophthalmol. 2019;30:500\u20135.","journal-title":"Curr Opin Ophthalmol"},{"key":"1376_CR106","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/j.ophtha.2007.03.054","volume":"114","author":"DH Su","year":"2007","unstructured":"Su DH, Bacsal K, Chee SP, Flores JV, Lim WK, Cheng BC, et al. Prevalence of dengue maculopathy in patients hospitalized for dengue fever. Ophthalmology. 2007;114:1743\u20137. https:\/\/doi.org\/10.1016\/j.ophtha.2007.03.054.","journal-title":"Ophthalmology."},{"key":"1376_CR107","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ajo.2009.06.030","volume":"148","author":"E Chee","year":"2009","unstructured":"Chee E, Sims JL, Jap A, Tan BH, Oh H, Chee SP. Comparison of prevalence of dengue maculopathy during two epidemics with differing predominant serotypes. Am J Ophthalmol. 2009;148:910\u20133. https:\/\/doi.org\/10.1016\/j.ajo.2009.06.030.","journal-title":"Am J Ophthalmol"},{"key":"1376_CR108","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/IAE.0b013e3181bd2fc6","volume":"30","author":"SC Teoh","year":"2010","unstructured":"Teoh SC, Chee CK, Laude A, Goh KY, Barkham T, Ang BS, et al. Optical coherence tomography patterns as predictors of visual outcome in dengue-related maculopathy. Retina. 2010;30:390\u20138. https:\/\/doi.org\/10.1097\/IAE.0b013e3181bd2fc6.","journal-title":"Retina."},{"key":"1376_CR109","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1016\/j.jfo.2018.05.002","volume":"41","author":"H Merle","year":"2018","unstructured":"Merle H, Donnio A, Jean-Charles A, Guyomarch J, Hage R, Najioullah F, et al. Ocular manifestations of emerging arboviruses: dengue fever, chikungunya, Zika virus, West Nile virus, and yellow fever. J Fr Ophtalmol. 2018;41:e235\u201343. https:\/\/doi.org\/10.1016\/j.jfo.2018.05.002.","journal-title":"J Fr Ophtalmol"},{"key":"1376_CR110","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1001\/archopht.125.4.501","volume":"125","author":"KE Bacsal","year":"2007","unstructured":"Bacsal KE, Chee S-P, Cheng C-L, Flores JVP. Dengue-associated maculopathy. Arch Ophthalmol. 2007;125:501\u201310.","journal-title":"Arch Ophthalmol"},{"key":"1376_CR111","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3928\/23258160-20161031-12","volume":"47","author":"S Tavassoli","year":"2016","unstructured":"Tavassoli S, Carre\u00f1o E, Teoh SC, Theodoropoulou S, Bailey C, Lee RW, et al. Optical coherence tomography angiography findings in dengue-related maculopathy: a case report. Ophthalmic Surg Lasers Imaging. Retina. 2016;47:1057\u201360. https:\/\/doi.org\/10.3928\/23258160-20161031-12.","journal-title":"Retina."},{"key":"1376_CR112","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.coviro.2017.04.002","volume":"23","author":"I Scherwitzl","year":"2017","unstructured":"Scherwitzl I, Mongkolsapaja J, Screaton G. Recent advances in human flavivirus vaccines. Curr Opin Virol. 2017;23:95\u2013101.","journal-title":"Curr Opin Virol"},{"key":"1376_CR113","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jobm.201700398","volume":"58","author":"F Javed","year":"2018","unstructured":"Javed F, Manzoor KN, Ali M, Haq IU, Khan AA, Zaib A, et al. Zika virus: what we need to know? J Basic Microbiol. 2018;58:3\u201316. https:\/\/doi.org\/10.1002\/jobm.201700398.","journal-title":"J Basic Microbiol"},{"key":"1376_CR114","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00705-006-0903-z","volume":"152","author":"G Kuno","year":"2007","unstructured":"Kuno G, Chang G-JJ. Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses. Arch Virol. 2007;152:687\u201396.","journal-title":"Arch Virol"},{"key":"1376_CR115","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.preteyeres.2018.04.004","volume":"66","author":"JR de Oliveira Dias","year":"2018","unstructured":"de Oliveira Dias JR, Ventura CV, de Paula Freitas B, Prazeres J, Ventura LO, Bravo-Filho V, et al. Zika and the eye: pieces of a puzzle. Prog Retin Eye Res. 2018;66:85\u2013106. https:\/\/doi.org\/10.1016\/j.preteyeres.2018.04.004.","journal-title":"Prog Retin Eye Res"},{"key":"1376_CR116","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.survophthal.2017.06.001","volume":"63","author":"MC Marquezan","year":"2018","unstructured":"Marquezan MC, Ventura CV, Sheffield JS, Golden WC, Omiadze R, Belfort R Jr, et al. Ocular effects of Zika virus-a review. Surv Ophthalmol. 2018;63:166\u201373. https:\/\/doi.org\/10.1016\/j.survophthal.2017.06.001.","journal-title":"Surv Ophthalmol"},{"key":"1376_CR117","unstructured":"World Health Organisation. Zika virus. 2018. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/zika-virus."},{"key":"1376_CR118","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1001\/jamaophthalmol.2016.3417","volume":"134","author":"J Sun","year":"2016","unstructured":"Sun J, Wu D, Zhong H, Guan D, Zhang H, Tan Q, et al. Presence of Zika virus in conjunctival fluid. JAMA Ophthalmol. 2016;134:1330\u20132. https:\/\/doi.org\/10.1001\/jamaophthalmol.2016.3417.","journal-title":"JAMA Ophthalmol"},{"key":"1376_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09479-5","volume":"7","author":"JJL Tan","year":"2017","unstructured":"Tan JJL, Balne PK, Leo YS, Tong L, Ng LFP, Agrawal R. Persistence of Zika virus in conjunctival fluid of convalescence patients. Sci Rep. 2017;7:11194.","journal-title":"Sci Rep"},{"key":"1376_CR120","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1056\/NEJMoa1602412","volume":"375","author":"P Brasil","year":"2016","unstructured":"Brasil P, Pereira JP Jr, Moreira ME, Ribeiro Nogueira RM, Damasceno L, Wakimoto M, et al. Zika virus infection in pregnant women in Rio de Janeiro. N Engl J Med. 2016;375:2321\u201334. https:\/\/doi.org\/10.1056\/NEJMoa1602412.","journal-title":"N Engl J Med"},{"key":"1376_CR121","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1056\/NEJMoa0805715","volume":"360","author":"MR Duffy","year":"2009","unstructured":"Duffy MR, Chen TH, Hancock WT, Powers AM, Kool JL, Lanciotti RS, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med. 2009;360:2536\u201343. https:\/\/doi.org\/10.1056\/NEJMoa0805715.","journal-title":"N Engl J Med"},{"key":"1376_CR122","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1056\/NEJMra1602113","volume":"374","author":"LR Petersen","year":"2016","unstructured":"Petersen LR, Jamieson DJ, Powers AM, Honein MA. Zika Virus. N Engl J Med 2016;374:1552\u201363.","journal-title":"N Engl J Med"},{"key":"1376_CR123","doi-asserted-by":"publisher","first-page":"910","DOI":"10.15585\/mmwr.mm6534e1","volume":"65","author":"E Dirlikov","year":"2016","unstructured":"Dirlikov E, Major CG, Mayshack M, Medina N, Matos D, Ryff KR, et al. Guillain-Barr\u00e9 syndrome during ongoing Zika virus transmission\u2014Puerto Rico, January 1\u2013July 31, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:910\u20134. https:\/\/doi.org\/10.15585\/mmwr.mm6534e1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1376_CR124","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jamapediatrics.2016.3982","volume":"171","author":"CA Moore","year":"2017","unstructured":"Moore CA, Staples JE, Dobyns WB, Pessoa A, Ventura CV, Fonseca EB, et al. Characterizing the pattern of anomalies in congenital Zika syndrome for pediatric clinicians. JAMA Pediatr. 2017;171:288\u201395. https:\/\/doi.org\/10.1001\/jamapediatrics.2016.3982.","journal-title":"JAMA Pediatr"},{"key":"1376_CR125","doi-asserted-by":"publisher","first-page":"615","DOI":"10.15585\/mmwr.mm6623e1","volume":"66","author":"CK Shapiro-Mendoza","year":"2017","unstructured":"Shapiro-Mendoza CK, Rice ME, Galang RR, Fulton AC, VanMaldeghem K, Prado MV, et al. Pregnancy outcomes after maternal Zika virus infection during pregnancy\u2014U.S. Territories, January 1, 2016\u2013April 25, 2017. MMWR Morb Mortal Wkly Rep. 2017;66:615\u201321. https:\/\/doi.org\/10.15585\/mmwr.mm6623e1.","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"1376_CR126","unstructured":"CDC. Data & statistics on Zika and pregnancy|CDC. Centers for Disease Control and Prevention; 2019. https:\/\/www.cdc.gov\/pregnancy\/zika\/data\/index.html."},{"key":"1376_CR127","doi-asserted-by":"publisher","first-page":"S154","DOI":"10.1542\/peds.2017-2038D","volume":"141","author":"AC Wheeler","year":"2018","unstructured":"Wheeler AC. Development of infants with congenital Zika syndrome: what do we know and what can we expect? Pediatrics. 2018;141:S154\u201360.","journal-title":"Pediatrics"},{"key":"1376_CR128","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nrneurol.2016.71","volume":"12","author":"Z Moln\u00e1r","year":"2016","unstructured":"Moln\u00e1r Z, Kennedy S. Neurodevelopmental disorders: risks of Zika virus during the first trimester of pregnancy. Nat Rev Neurol. 2016;12:315\u20136.","journal-title":"Nat Rev Neurol"},{"key":"1376_CR129","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.3201\/eid2207.160375","volume":"22","author":"J Cerbino-Neto","year":"2016","unstructured":"Cerbino-Neto J, Mesquita EC, Souza TM, Parreira V, Wittlin BB, Durovni B, et al. Clinical manifestations of Zika virus infection, Rio de Janeiro, Brazil, 2015. Emerg Infect Dis. 2016;22:1318\u201320. https:\/\/doi.org\/10.3201\/eid2207.160375.","journal-title":"Emerg Infect Dis"},{"key":"1376_CR130","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/ceo.13450","volume":"47","author":"GF Oliver","year":"2019","unstructured":"Oliver GF, Carr JM, Smith JR. Emerging infectious uveitis: Chikungunya, dengue, Zika and Ebola: a review. Clin Exp Ophthalmol. 2019;47:372\u201380.","journal-title":"Clin Exp Ophthalmol"},{"key":"1376_CR131","doi-asserted-by":"publisher","unstructured":"Furtado JM, Esp\u00f3sito DL, Klein TM, Teixeira-Pinto T, da Fonseca BA. Uveitis associated with Zika virus infection. 2016. https:\/\/doi.org\/10.1056\/NEJMc1603618.","DOI":"10.1056\/NEJMc1603618"},{"key":"1376_CR132","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5935\/0004-2749.20160020","volume":"79","author":"BM Fontes","year":"2016","unstructured":"Fontes BM, Fontes BM. Iridociclite hipertensiva associada \u00e0 infec\u00e7\u00e3o por Zika v\u00edrus. Arq Bras Oftalmol. 2016;79:63.","journal-title":"Arq Bras Oftalmol"},{"key":"1376_CR133","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1001\/jamaophthalmol.2016.5689","volume":"135","author":"H Merle","year":"2017","unstructured":"Merle H, Najioullah F, Chassery M, C\u00e9saire R, Hage R. Zika-related bilateral hypertensive anterior acute uveitis. JAMA Ophthalmol. 2017;135:284\u20135.","journal-title":"JAMA Ophthalmol"},{"key":"1376_CR134","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.idcr.2017.06.010","volume":"9","author":"A Panday","year":"2017","unstructured":"Panday A, Sandy S, King D, Ramdeen S. A case of suspected symptomatic Zika neuroretinitis. IDCases. 2017;9:104\u20135.","journal-title":"IDCases"},{"key":"1376_CR135","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1001\/jamaophthalmol.2017.0098","volume":"135","author":"CR Henry","year":"2017","unstructured":"Henry CR, Al-Attar L, Cruz-Chac\u00f3n AM, Davis JL. Chorioretinal lesions presumed secondary to Zika virus infection in an immunocompromised adult. JAMA Ophthalmol. 2017;135:386\u20139.","journal-title":"JAMA Ophthalmol"},{"key":"1376_CR136","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(16)32518-1","volume":"389","author":"S Kodati","year":"2017","unstructured":"Kodati S, Palmore TN, Spellman FA, Cunningham D, Weistrop B, Sen HN. Bilateral posterior uveitis associated with Zika virus infection. Lancet. 2017;389:125\u20136. https:\/\/doi.org\/10.1016\/S0140-6736(16)32518-1.","journal-title":"Lancet."},{"key":"1376_CR137","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/ICB.0000000000000552","volume":"13","author":"CW Wong","year":"2019","unstructured":"Wong CW, Ng SR, Cheung CMG, Wong TY, Mathur R. Zika-related maculopathy. Retin Cases Brief Rep. 2019;13:171\u20133.","journal-title":"Retin Cases Brief Rep"},{"key":"1376_CR138","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1016\/j.ophtha.2016.06.039","volume":"123","author":"DW Parke 3rd","year":"2016","unstructured":"Parke DW 3rd, Almeida DR, Albini TA, Ventura CV, Berrocal AM, Mittra RA. Serologically confirmed Zika-related unilateral acute maculopathy in an adult. Ophthalmology. 2016;123:2432\u20133. https:\/\/doi.org\/10.1016\/j.ophtha.2016.06.039.","journal-title":"Ophthalmology."},{"key":"1376_CR139","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1001\/jamaophthalmol.2016.1784","volume":"134","author":"CV Ventura","year":"2016","unstructured":"Ventura CV, Maia M, Travassos SB, Martins TT, Patriota F, Nunes ME, et al. Risk factors associated with the ophthalmoscopic findings identified in infants with presumed Zika virus congenital infection. JAMA Ophthalmol. 2016;134:912\u20138. https:\/\/doi.org\/10.1001\/jamaophthalmol.2016.1784.","journal-title":"JAMA Ophthalmol"},{"key":"1376_CR140","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/jamaophthalmol.2016.0267","volume":"134","author":"B de Paula Freitas","year":"2016","unstructured":"de Paula Freitas B, de Oliveira Dias JR, Prazeres J, Sacramento GA, Ko AI, Maia M, et al. Ocular findings in infants with microcephaly associated with presumed Zika virus congenital infection in Salvador, Brazil. JAMA Ophthalmol. 2016;134:529\u201335. https:\/\/doi.org\/10.1001\/jamaophthalmol.2016.0267.","journal-title":"Brazil. JAMA Ophthalmol."},{"key":"1376_CR141","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/RMR.0000000000000192","volume":"28","author":"CV Ventura","year":"2019","unstructured":"Ventura CV, Ventura Filho MC, Ventura LO. Ocular manifestations and visual outcome in children with congenital Zika syndrome. Top Magn Reson Imaging TMRI. 2019;28:23\u20137.","journal-title":"Top Magn Reson Imaging TMRI"},{"key":"1376_CR142","doi-asserted-by":"publisher","first-page":"e92340","DOI":"10.1172\/jci.insight.92340","volume":"2","author":"PK Singh","year":"2017","unstructured":"Singh PK, Guest JM, Kanwar M, Boss J, Gao N, Juzych MS, et al. Zika virus infects cells lining the blood-retinal barrier and causes chorioretinal atrophy in mouse eyes. JCI Insight. 2017;2:e92340. https:\/\/doi.org\/10.1172\/jci.insight.92340.","journal-title":"JCI Insight"},{"key":"1376_CR143","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1523\/JNEUROSCI.3124-16.2017","volume":"37","author":"AN van den Pol","year":"2017","unstructured":"van den Pol AN, van den, Mao G, Yang Y, Ornaghi S, Davis JN. Zika virus targeting in the developing brain. J Neurosci. 2017;37:2161\u201375.","journal-title":"J Neurosci"},{"key":"1376_CR144","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1001\/jamaophthalmol.2017.3595","volume":"135","author":"MP Fernandez","year":"2017","unstructured":"Fernandez MP, Parra Saad E, Ospina Martinez M, Corchuelo S, Mercado Reyes M, Herrera MJ, et al. Ocular Histopathologic features of congenital Zika syndrome. JAMA Ophthalmol. 2017;135:1163\u20139. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.3595.","journal-title":"JAMA Ophthalmol"},{"key":"1376_CR145","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1016\/j.ophtha.2017.06.009","volume":"124","author":"B de Paula Freitas","year":"2017","unstructured":"de Paula Freitas B, Zin A, Ko A, Maia M, Ventura CV, Belfort R Jr. Anterior-Segment Ocular Findings and Microphthalmia in Congenital Zika Syndrome. Ophthalmology. 2017;124:1876\u20138. https:\/\/doi.org\/10.1016\/j.ophtha.2017.06.009.","journal-title":"Ophthalmology."},{"key":"1376_CR146","unstructured":"WHO. Laboratory testing for Zika virus infection. WHO; 2016. http:\/\/www.who.int\/csr\/resources\/publications\/zika\/laboratory-testing\/en\/."},{"key":"1376_CR147","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.15585\/mmwr.mm6641a1","volume":"66","author":"T Adebanjo","year":"2017","unstructured":"Adebanjo T, Godfred-Cato S, Viens L, Fischer M, Staples JE, Kuhnert-Tallman W, et al. Update: interim guidance for the diagnosis, evaluation, and management of infants with possible congenital Zika virus infection\u2013United States, October 2017. MMWR Morb Mortal Wkly Rep. 2017:66:1089\u201399 https:\/\/doi.org\/10.15585\/mmwr.mm6641a1.","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"1376_CR148","doi-asserted-by":"publisher","first-page":"63","DOI":"10.15585\/mmwr.mm6503e3","volume":"65","author":"JE Staples","year":"2016","unstructured":"Staples JE, Dziuban EJ, Fischer M, Cragan JD, Rasmussen SA, Cannon MJ, et al. Interim guidelines for the evaluation and testing of infants with possible congenital Zika virus infection\u2014United States, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:63\u20137. https:\/\/doi.org\/10.15585\/mmwr.mm6503e3.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1376_CR149","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jaapos.2017.07.206","volume":"21","author":"LO Ventura","year":"2017","unstructured":"Ventura LO, Lawrence L, Ventura CV, Dutton GN, Marinho P, Ferro PF, et al. Response to correction of refractive errors and hypoaccommodation in children with congenital Zika syndrome. J AAPOS. 2017;21:480\u20134.e1. https:\/\/doi.org\/10.1016\/j.jaapos.2017.07.206.","journal-title":"J AAPOS"},{"key":"1376_CR150","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1001\/jama.2013.8042","volume":"310","author":"LR Petersen","year":"2013","unstructured":"Petersen LR, Brault AC, Nasci RS. West Nile virus: review of the literature. JAMA. 2013;310:308\u201315.","journal-title":"JAMA"},{"key":"1376_CR151","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.survophthal.2004.10.001","volume":"50","author":"S Garg","year":"2005","unstructured":"Garg S, Jampol LM. Systemic and intraocular manifestations of West Nile virus infection. Surv Ophthalmol. 2005;50:3\u201313.","journal-title":"Surv Ophthalmol"},{"key":"1376_CR152","unstructured":"World Health Organisation. West Nile virus. 2017. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/west-nile-virus."},{"key":"1376_CR153","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1086\/656602","volume":"202","author":"S Zou","year":"2010","unstructured":"Zou S, Foster GA, Dodd RY, Petersen LR, Stramer SL. West Nile fever characteristics among viremic persons identified through blood donor screening. J Infect Dis. 2010;202:1354\u201361.","journal-title":"J Infect Dis"},{"key":"1376_CR154","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0140-6736(01)05480-0","volume":"358","author":"F Mostashari","year":"2001","unstructured":"Mostashari F, Bunning ML, Kitsutani PT, Singer DA, Nash D, Cooper MJ, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet. 2001;358:261\u20134. https:\/\/doi.org\/10.1016\/S0140-6736(01)05480-0.","journal-title":"Lancet."},{"key":"1376_CR155","unstructured":"Lindsey N, Staples E, Lehman J, Fischer M. Surveillance for human West Nile virus disease\u2014United States, 1999\u20132008. 2010. https:\/\/www.cdc.gov\/mmwr\/preview\/mmWrhtml\/ss5902a1.htm."},{"key":"1376_CR156","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1017\/s0317167100053828","volume":"31","author":"JM Burton","year":"2004","unstructured":"Burton JM, Kern RZ, Halliday W, Mikulis D, Brunton J, Fearon M, et al. Neurological manifestations of West Nile virus infection. Can J Neurol Sci. 2004;31:185\u201393. https:\/\/doi.org\/10.1017\/s0317167100053828.","journal-title":"Can J Neurol Sci"},{"key":"1376_CR157","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/j.ophtha.2004.03.032","volume":"111","author":"M Khairallah","year":"2004","unstructured":"Khairallah M, Ben Yahia S, Ladjimi A, Zeghidi H, Ben Romdhane F, Besbes L, et al. Chorioretinal involvement in patients with West Nile virus infection. Ophthalmology. 2004;111:2065\u201370. https:\/\/doi.org\/10.1016\/j.ophtha.2004.03.032.","journal-title":"Ophthalmology."},{"key":"1376_CR158","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1016\/j.ophtha.2013.02.006","volume":"120","author":"RR Sivakumar","year":"2013","unstructured":"Sivakumar RR, Prajna L, Arya LK, Muraly P, Shukla J, Saxena D, et al. Molecular diagnosis and ocular imaging of West Nile virus retinitis and neuroretinitis. Ophthalmology. 2013;120:1820\u20136. https:\/\/doi.org\/10.1016\/j.ophtha.2013.02.006.","journal-title":"Ophthalmology."},{"key":"1376_CR159","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.optm.2005.08.015","volume":"76","author":"SB Koevary","year":"2005","unstructured":"Koevary SB. Ocular involvement in patients infected by the West Nile virus. Optometry. 2005;76:609\u201312.","journal-title":"Optometry"},{"key":"1376_CR160","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.survophthal.2016.12.008","volume":"62","author":"JH Lee","year":"2017","unstructured":"Lee JH, Agarwal A, Mahendradas P, Lee CS, Gupta V, Pavesio CE, et al. Viral posterior uveitis. Surv Ophthalmol. 2017;62:404\u201345. https:\/\/doi.org\/10.1016\/j.survophthal.2016.12.008.","journal-title":"Surv Ophthalmol"},{"key":"1376_CR161","doi-asserted-by":"publisher","first-page":"114","DOI":"10.7150\/ijms.6.114","volume":"6","author":"SB Yahia","year":"2009","unstructured":"Yahia SB, Khairallah M. Ocular manifestations of West Nile virus infection. Int J Med Sci. 2009;6:114\u20135.","journal-title":"Int J Med Sci"},{"key":"1376_CR162","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.ophtha.2006.04.021","volume":"113","author":"CK Chan","year":"2006","unstructured":"Chan CK, Limstrom SA, Tarasewicz DG, Lin SG. Ocular features of west nile virus infection in North America: a study of 14 eyes. Ophthalmology. 2006;113:1539\u201346.","journal-title":"Ophthalmology"},{"key":"1376_CR163","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/09273940701798488","volume":"15","author":"M Khairallah","year":"2007","unstructured":"Khairallah M, Yahia SB, Letaief M, Attia S, Kahloun R, Jelliti B, et al. A prospective evaluation of factors associated with chorioretinitis in patients with West Nile virus infection. Ocul Immunol Inflamm. 2007;15:435\u20139. https:\/\/doi.org\/10.1080\/09273940701798488.","journal-title":"Ocul Immunol Inflamm"},{"key":"1376_CR164","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.tim.2018.05.012","volume":"26","author":"F Douam","year":"2018","unstructured":"Douam F, Ploss A. Yellow fever virus: Knowledge gaps impeding the fight against an old foe. Trends Microbiol. 2018;26:913\u201328.","journal-title":"Trends Microbiol"},{"key":"1376_CR165","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S1473-3099(01)00016-0","volume":"1","author":"TP Monath","year":"2001","unstructured":"Monath TP. Yellow fever: an update. Lancet Infect Dis. 2001;1:11\u201320.","journal-title":"Lancet Infect Dis"},{"key":"1376_CR166","unstructured":"World Health Organisation. Yellow fever. 2019. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/yellow-fever."},{"key":"1376_CR167","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1001\/jamaophthalmol.2018.6408","volume":"137","author":"S Vianello","year":"2019","unstructured":"Vianello S, Silva de Souza G, Maia M, Belfort R, de Oliveira Dias JR. Ocular findings in Yellow fever infection. JAMA Ophthalmol. 2019;137:300\u20134.","journal-title":"JAMA Ophthalmol"},{"key":"1376_CR168","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/09273948.2018.1510529","volume":"27","author":"AL Biancardi","year":"2019","unstructured":"Biancardi AL, Moraes HVde. Anterior and intermediate uveitis following Yellow fever vaccination with fractional dose: case reports. Ocul Immunol Inflamm. 2019;27:521\u20133.","journal-title":"Ocul Immunol Inflamm"},{"key":"1376_CR169","doi-asserted-by":"publisher","unstructured":"Campos WR, Cenachi SPF, Soares MS, Gon\u00e7alves PF, Vasconcelos-Santos DV. Vogt-Koyanagi-Harada-like Disease following Yellow fever vaccination. Ocul Immunol Inflamm. 2019;1\u20134. https:\/\/doi.org\/10.1080\/09273948.2019.1661498.","DOI":"10.1080\/09273948.2019.1661498"},{"key":"1376_CR170","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMp1803433","volume":"379","author":"K Vannice","year":"2018","unstructured":"Vannice K, Wilder-Smith A, Hombach J. Fractional-dose yellow fever vaccination\u2014advancing the evidence base. N Engl J Med. 2018;379:603\u20135.","journal-title":"N Engl J Med"},{"key":"1376_CR171","doi-asserted-by":"publisher","DOI":"10.1186\/1869-5760-3-35","volume":"3","author":"P Mahendradas","year":"2013","unstructured":"Mahendradas P, Avadhani K, Shetty R. Chikungunya and the eye: a review. J Ophthalmic Inflamm Infect. 2013;3:35.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"1376_CR172","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3201\/eid1603.091403","volume":"16","author":"X Fritel","year":"2010","unstructured":"Fritel X, Rollot O, Gerardin P, Gauzere BA, Bideault J, Lagarde L, et al. Chikungunya virus infection during pregnancy, Reunion, France, 2006. Emerg Infect Dis. 2010;16:418\u201325. https:\/\/doi.org\/10.3201\/eid1603.091403.","journal-title":"Emerg Infect Dis"},{"key":"1376_CR173","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1016\/S1473-3099(16)30385-1","volume":"17","author":"FJ Burt","year":"2017","unstructured":"Burt FJ, Chen W, Miner JJ, Lenschow DJ, Merits A, Schnettler E, et al. Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen. Lancet Infect Dis. 2017;17:e107\u201317. https:\/\/doi.org\/10.1016\/S1473-3099(16)30385-1.","journal-title":"Lancet Infect Dis."},{"key":"1376_CR174","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3201\/eid1403.070720","volume":"14","author":"D Mavalankar","year":"2008","unstructured":"Mavalankar D, Shastri P, Bandyopadhyay T, Parmar J, Ramani KV. Increased mortality rate associated with Chikungunya epidemic, Ahmedabad, India. Emerg Infect Dis. 2008;14:412\u20135.","journal-title":"Emerg Infect Dis"},{"key":"1376_CR175","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ajo.2007.06.002","volume":"144","author":"P Lalitha","year":"2007","unstructured":"Lalitha P, Rathinam S, Banushree K, Maheshkumar S, Vijayakumar R, Sathe P. Ocular involvement associated with an epidemic outbreak of chikungunya virus infection. Am J Ophthalmol. 2007;144:552\u20136. https:\/\/doi.org\/10.1016\/j.ajo.2007.06.002.","journal-title":"Am J Ophthalmol"},{"key":"1376_CR176","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3109\/09273948.2013.841482","volume":"22","author":"K Babu","year":"2014","unstructured":"Babu K, Kini R, Philips M, Subbakrishna DK. Clinical profile of isolated viral anterior uveitis in a South Indian patient population. Ocul Immunol Inflamm. 2014;22:356\u20139.","journal-title":"Ocul Immunol Inflamm"},{"key":"1376_CR177","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ophtha.2007.03.085","volume":"115","author":"P Mahendradas","year":"2008","unstructured":"Mahendradas P, Ranganna SK, Shetty R, Balu R, Narayana KM, Babu RB, et al. Ocular manifestations associated with chikungunya. Ophthalmology. 2008;115:287\u201391. https:\/\/doi.org\/10.1016\/j.ophtha.2007.03.085.","journal-title":"Ophthalmology."},{"key":"1376_CR178","doi-asserted-by":"publisher","first-page":"329","DOI":"10.4103\/0301-4738.41419","volume":"56","author":"KR Murthy","year":"2008","unstructured":"Murthy KR, Venkataraman N, Satish V, Babu K. Bilateral retinitis following Chikungunya fever. Indian J Ophthalmol. 2008;56:329\u201331.","journal-title":"Indian J Ophthalmol"},{"key":"1376_CR179","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/ICB.0000000000000232","volume":"9","author":"NK Scripsema","year":"2015","unstructured":"Scripsema NK, Sharifi E, Samson CM, Kedhar S, Rosen RB. Chikungunya-associated uveitis and exudative retinal detachment: a case report. Retin Cases Brief Rep. 2015;9:352\u20136.","journal-title":"Retin Cases Brief Rep"},{"key":"1376_CR180","doi-asserted-by":"publisher","unstructured":"Salceanu SO, Raman V. BMJ Case Rep. 2018. https:\/\/doi.org\/10.1136\/bcr-2017-222864.","DOI":"10.1136\/bcr-2017-222864"},{"key":"1376_CR181","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/archopht.125.10.1381","volume":"125","author":"A Mittal","year":"2007","unstructured":"Mittal A, Mittal S, Bharati MJ, Ramakrishnan R, Saravanan S, Sathe PS. Optic neuritis associated with chikungunya virus infection in South India. Arch Ophthalmol. 2007;125:1381\u20136. https:\/\/doi.org\/10.1001\/archopht.125.10.1381.","journal-title":"Arch Ophthalmol"},{"key":"1376_CR182","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/infdis\/jis296","volume":"206","author":"T Couderc","year":"2012","unstructured":"Couderc T, Gangneux N, Chr\u00e9tien F, Caro V, Le Luong T, Ducloux B, et al. Chikungunya virus infection of corneal grafts. J Infect Dis. 2012;206:851\u20139. https:\/\/doi.org\/10.1093\/infdis\/jis296.","journal-title":"J Infect Dis"},{"key":"1376_CR183","unstructured":"World Health Organisation. Chikungunya. 2020. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/chikungunya."},{"key":"1376_CR184","doi-asserted-by":"publisher","first-page":"545","DOI":"10.4103\/0301-4738.71707","volume":"58","author":"P Mahendradas","year":"2010","unstructured":"Mahendradas P, Shetty R, Malathi J, Madhavan HN. Chikungunya virus iridocyclitis in Fuchs\u2019 heterochromic iridocyclitis. Indian J Ophthalmol. 2010;58:545\u20137.","journal-title":"Indian J Ophthalmol"},{"key":"1376_CR185","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/13543776.2020.1751817","volume":"30","author":"R Ghildiyal","year":"2020","unstructured":"Ghildiyal R, Gabrani R. Antiviral therapeutics for chikungunya virus. Expert Opin Ther Pat. 2020;30:467\u201380. https:\/\/doi.org\/10.1080\/13543776.2020.1751817.","journal-title":"Expert Opin Ther Pat"},{"key":"1376_CR186","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.3389\/fmicb.2019.02881","volume":"10","author":"S Gao","year":"2019","unstructured":"Gao S, Song S, Zhang L. Recent progress in vaccine development against chikungunya virus. Front Microbiol. 2019;10:2881. https:\/\/doi.org\/10.3389\/fmicb.2019.02881.","journal-title":"Front Microbiol"},{"key":"1376_CR187","doi-asserted-by":"publisher","first-page":"e0008094","DOI":"10.1371\/journal.pntd.0008094","volume":"14","author":"L Monsalve-Arteaga","year":"2020","unstructured":"Monsalve-Arteaga L, Alonso-Sard\u00f3n M, Mu\u00f1oz Bellido JL, Vicente Santiago MB, Vieira Lista MC, L\u00f3pez Ab\u00e1n J, et al. Seroprevalence of Crimean-Congo hemorrhagic fever in humans in the World Health Organization European region: a systematic review. PLoS Negl Trop Dis. 2020;14:e0008094. https:\/\/doi.org\/10.1371\/journal.pntd.0008094.","journal-title":"PLoS Negl Trop Dis"},{"key":"1376_CR188","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.antiviral.2004.08.001","volume":"64","author":"CA Whitehouse","year":"2004","unstructured":"Whitehouse CA. Crimean-Congo hemorrhagic fever. Antivir Res. 2004;64:145\u201360.","journal-title":"Antivir Res"},{"key":"1376_CR189","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3201\/eid1804.111374","volume":"18","author":"H Bodur","year":"2012","unstructured":"Bodur H, Akinci E, Ascioglu S, \u00d6ng\u00fcr\u00fc P, Uyar Y. Subclinical infections with Crimean-Congo hemorrhagic fever virus, Turkey. Emerg Infect Dis. 2012;18:640\u20132.","journal-title":"Emerg Infect Dis"},{"key":"1376_CR190","unstructured":"CDC. Signs and symptoms | Crimean-Congo hemorrhagic fever (CCHF) | 2019;CDC. https:\/\/www.cdc.gov\/vhf\/crimean-congo\/symptoms\/index.html."},{"key":"1376_CR191","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.ajo.2008.11.014","volume":"147","author":"A Engin","year":"2009","unstructured":"Engin A, Erdogan H, Ozec AV, Elaldi N, Toker MI, Bakir M, et al. Ocular findings in patients with Crimean-Congo hemorrhagic fever. Am J Ophthalmol. 2009;147:634\u20138.e1. https:\/\/doi.org\/10.1016\/j.ajo.2008.11.014.","journal-title":"Am J Ophthalmol"},{"key":"1376_CR192","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1473-3099(06)70435-2","volume":"6","author":"\u00d6 Erg\u00f6n\u00fcl","year":"2006","unstructured":"Erg\u00f6n\u00fcl \u00d6. Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 2006;6:203\u201314.","journal-title":"Lancet Infect Dis"},{"key":"1376_CR193","unstructured":"World Health Organisation. Crimean-Congo haemorrhagic fever. 2013. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/crimean-congo-haemorrhagic-fever."},{"key":"1376_CR194","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5.","journal-title":"Lancet."},{"key":"1376_CR195","unstructured":"COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). https:\/\/coronavirus.jhu.edu\/map.html. Accessed 18 Jan 2021."},{"key":"1376_CR196","unstructured":"World Health Organisation. Transmission of SARS-CoV-2: implications for infection prevention precautions. Sci Brief. 2020. https:\/\/www.who.int\/news-room\/commentaries\/detail\/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions."},{"key":"1376_CR197","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708\u201320. https:\/\/doi.org\/10.1056\/NEJMoa2002032.","journal-title":"N Engl J Med."},{"key":"1376_CR198","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/jmv.25725","volume":"92","author":"J Xia","year":"2020","unstructured":"Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020;92:589\u201394.","journal-title":"J Med Virol"},{"key":"1376_CR199","doi-asserted-by":"publisher","first-page":"242","DOI":"10.7326\/M20-1176","volume":"173","author":"F Colavita","year":"2020","unstructured":"Colavita F, Lapa D, Carletti F, Lalle E, Bordi L, Marsella P, et al. SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann Intern Med. 2020;173:242\u20133. https:\/\/doi.org\/10.7326\/M20-1176.","journal-title":"Ann Intern Med"},{"key":"1376_CR200","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/S0140-6736(20)31014-X","volume":"395","author":"PM Marinho","year":"2020","unstructured":"Marinho PM, Marcos AAA, Romano AC, Nascimento H, Belfort R Jr. Retinal findings in patients with COVID-19. Lancet. 2020;395:1610. https:\/\/doi.org\/10.1016\/S0140-6736(20)31014-X.","journal-title":"Lancet."},{"key":"1376_CR201","doi-asserted-by":"publisher","unstructured":"Zhou Y, Zeng Y, Tong Y, Chen C. Ophthalmologic evidence against the interpersonal transmission of 2019 novel coronavirus through conjunctiva. medRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.02.11.20021956.","DOI":"10.1101\/2020.02.11.20021956"},{"key":"1376_CR202","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/S0140-6736(20)31014-X","volume":"395","author":"PM Marinho","year":"2020","unstructured":"Marinho PM, Marcos AAA, Romano AC, Nascimento H, Belfort R. Retinal findings in patients with COVID-19. Lancet. 2020;395:1610.","journal-title":"Lancet"},{"key":"1376_CR203","doi-asserted-by":"publisher","first-page":"e286","DOI":"10.1016\/S2589-7500(20)30086-8","volume":"2","author":"K Thorlund","year":"2020","unstructured":"Thorlund K, Dron L, Park J, Hsu G, Forrest JI, Mills EJ. A real-time dashboard of clinical trials for COVID-19. Lancet Digit Health. 2020;2:e286\u20137. https:\/\/doi.org\/10.1016\/S2589-7500(20)30086-8.","journal-title":"Lancet Digit Health."},{"key":"1376_CR204","doi-asserted-by":"publisher","unstructured":"Dong J, Ismail N, Walker DH. Chapter 15\u2014molecular testing in emerging infectious diseases. In: Diagnostic molecular pathology, editors. Coleman WB, Tsongalis GJ. Academic Press; 2017. p. 179\u2013200. https:\/\/doi.org\/10.1016\/B978-0-12-800886-7.00015-7.","DOI":"10.1016\/B978-0-12-800886-7.00015-7"},{"key":"1376_CR205","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nature08157","volume":"459","author":"G Neumann","year":"2009","unstructured":"Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature. 2009;459:931\u20139.","journal-title":"Nature"},{"key":"1376_CR206","doi-asserted-by":"publisher","first-page":"020421","DOI":"10.7189\/jogh.09.020421","volume":"9","author":"J Paget","year":"2019","unstructured":"Paget J, Spreeuwenberg P, Charu V, Taylor RJ, Iuliano AD, Bresee J, et al. Global mortality associated with seasonal influenza epidemics: new burden estimates and predictors from the GLaMOR project. J Glob Health. 2019;9:020421. https:\/\/doi.org\/10.7189\/jogh.09.020421.","journal-title":"J Glob Health"},{"key":"1376_CR207","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jhin.2015.08.027","volume":"92","author":"JA Otter","year":"2016","unstructured":"Otter JA, Donskey C, Yezli S, Douthwaite S, Goldenberg SD, Weber DJ. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect. 2016;92:235\u201350. https:\/\/doi.org\/10.1016\/j.jhin.2015.08.027.","journal-title":"J Hosp Infect"},{"key":"1376_CR208","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.2353\/ajpath.2010.091087","volume":"176","author":"MC Chan","year":"2010","unstructured":"Chan MC, Chan RW, Yu WC, Ho CC, Yuen KM, Fong JH, et al. Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. Am J Pathol. 2010;176:1828\u201340. https:\/\/doi.org\/10.2353\/ajpath.2010.091087.","journal-title":"Am J Pathol."},{"key":"1376_CR209","unstructured":"CDC. Flu symptoms & complications. Centers for Disease Control and Prevention; 2019. https:\/\/www.cdc.gov\/flu\/symptoms\/symptoms.htm."},{"key":"1376_CR210","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0039-6257(93)90064-E","volume":"37","author":"SL Yoser","year":"1993","unstructured":"Yoser SL, Forster DJ, Rao NA. Systemic viral infections and their retinal and choroidal manifestations. Surv Ophthalmol. 1993;37:313\u201352.","journal-title":"Surv Ophthalmol"},{"key":"1376_CR211","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000337138","volume":"48","author":"DEAA Mansour","year":"2012","unstructured":"Mansour DEAA, El-Shazly AA-F, Elawamry AI, Ismail AT. Comparison of ocular findings in patients with H1N1 influenza infection versus patients receiving influenza vaccine during a pandemic. Ophthalmic Res. 2012;48:134\u20138.","journal-title":"Ophthalmic Res"},{"key":"1376_CR212","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.ophtha.2010.03.013","volume":"117","author":"M Roesel","year":"2010","unstructured":"Roesel M, Heinz C, Heiligenhaus A. H1N1 and uveal effusion syndrome. Ophthalmology. 2010;117:1467\u20131467.e1.","journal-title":"Ophthalmology"},{"key":"1376_CR213","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3129\/i10-030","volume":"45","author":"OS Faridi","year":"2010","unstructured":"Faridi OS, Ranchod TM, Ho LY, Ruby AJ. Pandemic 2009 influenza A H1N1 retinopathy. Can J Ophthalmol J Can Ophtalmol. 2010;45:286\u20137.","journal-title":"Can J Ophthalmol J Can Ophtalmol"},{"key":"1376_CR214","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0002-9394(21)00233-6","volume":"103","author":"RJ Rabon","year":"1987","unstructured":"Rabon RJ, Louis GJ, Zegarra H, Gutman FA. Acute bilateral posterior angiopathy with influenza A viral infection. Am J Ophthalmol. 1987;103:289\u201393.","journal-title":"Am J Ophthalmol"},{"key":"1376_CR215","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s10384-006-0358-5","volume":"50","author":"T Jo","year":"2006","unstructured":"Jo T, Mizota A, Hatano N, Tanaka M. Frosted branch angiitis-like fundus following presumed influenza virus type A infection. Jpn J Ophthalmol. 2006;50:563\u20134.","journal-title":"Jpn J Ophthalmol"},{"key":"1376_CR216","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3109\/09273948.2012.674611","volume":"20","author":"L Rifkin","year":"2012","unstructured":"Rifkin L, Schaal S. H1N1-associated acute retinitis. Ocul Immunol Inflamm. 2012;20:230\u20132.","journal-title":"Ocul Immunol Inflamm"},{"key":"1376_CR217","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.3928\/01913913-20110628-03","volume":"48","author":"CC Lai","year":"2011","unstructured":"Lai CC, Chang YS, Li ML, Chang CM, Huang FC, Tseng SH. Acute anterior uveitis and optic neuritis as ocular complications of influenza A infection in an 11-year-old boy. J Pediatr Ophthalmol Strabismus. 2011;48:e30\u20133. https:\/\/doi.org\/10.3928\/01913913-20110628-03.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"1376_CR218","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/ICB.0000000000000118","volume":"9","author":"AY Cheung","year":"2015","unstructured":"Cheung AY, Anderson B, Stec L, Khandhar P, Williams GA. Bilateral vaso-occlusive retinal vasculitis with h1n1 influenza a infection. Retin Cases Brief Rep. 2015;9:138\u201341.","journal-title":"Retin Cases Brief Rep"},{"key":"1376_CR219","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/IMCRJ.S113217","volume":"10","author":"H Nakagawa","year":"2017","unstructured":"Nakagawa H, Noma H, Kotake O, Motohashi R, Yasuda K, Shimura M. Optic neuritis and acute anterior uveitis associated with influenza A infection: a case report. Int Med Case Rep J. 2017;10:1\u20135. https:\/\/doi.org\/10.2147\/IMCRJ.S113217.","journal-title":"Int Med Case Rep J"},{"key":"1376_CR220","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/WNO.0b013e31823fd913","volume":"32","author":"JH Pula","year":"2012","unstructured":"Pula JH, Issawi A, Desanto JR, Kattah JC. Cortical vision loss as a prominent feature of H1N1 encephalopathy. J Neuro-Ophthalmol J North Am Neuro-Ophthalmol Soc. 2012;32:48\u201350.","journal-title":"J Neuro-Ophthalmol J North Am Neuro-Ophthalmol Soc"},{"key":"1376_CR221","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/WNO.0000000000000247","volume":"35","author":"DA Breker","year":"2015","unstructured":"Breker DA, Stacey AW, Srinivasan A, Bursztyn LL, Trobe JD, Johnson MW. Vision loss caused by retinal and lateral geniculate nucleus infarction in H1N1 influenza. J Neuroophthalmol. 2015;35:265\u20139. https:\/\/doi.org\/10.1097\/WNO.0000000000000247.","journal-title":"J Neuroophthalmol"},{"key":"1376_CR222","doi-asserted-by":"publisher","first-page":"bcr2015212667","DOI":"10.1136\/bcr-2015-212667","volume":"2015","author":"J Tom\u00e1s","year":"2015","unstructured":"Tom\u00e1s J, Mac\u00e1rio MC, Gaspar E, Santana I. Severe post-influenza (H1N1) encephalitis involving pulvinar nuclei in an adult patient. BMJ Case Rep. 2015;2015:bcr2015212667. https:\/\/doi.org\/10.1136\/bcr-2015-212667.","journal-title":"BMJ Case Rep."},{"key":"1376_CR223","unstructured":"CDC. Overview of influenza testing methods. 2019. https:\/\/www.cdc.gov\/flu\/professionals\/diagnosis\/overview-testing-methods.htm."},{"key":"1376_CR224","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciy866","volume":"68","author":"TM Uyeki","year":"2019","unstructured":"Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM, Fry AM, et al. Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa. Clin Infect Dis. 2019;68:e1\u201347. https:\/\/doi.org\/10.1093\/cid\/ciy866.","journal-title":"Clin Infect Dis"},{"key":"1376_CR225","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1016\/S1473-3099(20)30123-7","volume":"20","author":"S Simpson","year":"2020","unstructured":"Simpson S, Kaufmann MC, Glozman V, Chakrabarti A. Disease X: accelerating the development of medical countermeasures for the next pandemic. Lancet Infect Dis. 2020;20:e108\u201315. https:\/\/doi.org\/10.1016\/S1473-3099(20)30123-7.","journal-title":"Lancet Infect Dis."},{"key":"1376_CR226","doi-asserted-by":"publisher","unstructured":"Aiello F, et al. Coronavirus disease 2019 (SARS-CoV-2) and colonization of ocular tissues and secretions: a systematic review. Eye. 2020;1\u20136. https:\/\/doi.org\/10.1038\/s41433-020-0926-9.","DOI":"10.1038\/s41433-020-0926-9"},{"key":"1376_CR227","first-page":"349","volume":"107","author":"DH Walker","year":"1982","unstructured":"Walker DH, McCormick JB, Johnson KM, Webb PA, Komba-Kono G, Elliott LH, et al. Pathologic and virologic study of fatal Lassa fever in man. Am J Pathol. 1982;107:349\u201356.","journal-title":"Am J Pathol"},{"key":"1376_CR228","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/JOM.0000000000000448","volume":"57","author":"RM Jones","year":"2015","unstructured":"Jones RM, Brosseau LM. Aerosol transmission of infectious disease. J Occup Environ Med. 2015;57:501\u20138.","journal-title":"J Occup Environ Med"},{"key":"1376_CR229","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/APO.0000000000000280","volume":"9","author":"DSC Lam","year":"2020","unstructured":"Lam DSC, Wong RLM, Lai KHW, Ko CN, Leung HY, Lee VYW, et al. COVID-19: special precautions in ophthalmic practice and FAQs on personal protection and mask selection. Asia Pac J Ophthalmol. 2020;9:67\u201377. https:\/\/doi.org\/10.1097\/APO.0000000000000280.","journal-title":"Asia Pac J Ophthalmol"},{"key":"1376_CR230","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ophtha.2020.03.037","volume":"127","author":"JP Olivia Li","year":"2020","unstructured":"Olivia Li JP, Shantha J, Wong TY, Wong EY, Mehta J, Lin H, et al. Preparedness among ophthalmologists: during and beyond the COVID-19 pandemic. ophthalmology. 2020;127:569\u201372. https:\/\/doi.org\/10.1016\/j.ophtha.2020.03.037.","journal-title":"ophthalmology."},{"key":"1376_CR231","doi-asserted-by":"publisher","first-page":"225","DOI":"10.4103\/0974.9233.58426","volume":"16","author":"M Khairallah","year":"2009","unstructured":"Khairallah M, Jelliti B, Jenzeri S. Emergent infectious uveitis. Middle East Afr J Ophthalmol. 2009;16:225\u201338. https:\/\/doi.org\/10.4103\/0974.9233.58426.","journal-title":"Middle East Afr J Ophthalmol"},{"key":"1376_CR232","doi-asserted-by":"publisher","first-page":"e0148898","DOI":"10.1371\/journal.pone.0148898","volume":"11","author":"R Hasbun","year":"2016","unstructured":"Hasbun R, Garcia MN, Kellaway J, Baker L, Salazar L, Woods SP, et al. West Nile Virus retinopathy and associations with long term neurological and neurocognitive sequelae. PLoS ONE. 2016;11:e0148898. https:\/\/doi.org\/10.1371\/journal.pone.0148898.","journal-title":"PLoS ONE"},{"key":"1376_CR233","doi-asserted-by":"publisher","DOI":"10.1186\/1869-5760-3-35","volume":"3","author":"P Mahendradas","year":"2013","unstructured":"Mahendradas P, Avadhani K, Shetty R. Chikungunya and the eye: a review. J Ophthalmic Inflamm Infect. 2013;3:35. https:\/\/doi.org\/10.1186\/1869-5760-3-35.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"1376_CR234","doi-asserted-by":"publisher","first-page":"423672","DOI":"10.1155\/2010\/423672","volume":"2010","author":"MJ Lopez-Prats","year":"2010","unstructured":"Lopez-Prats MJ, Sanz Marco E, Hidalgo-Mora JJ, Garcia-Delpech S, Diaz-Llopis M. Bleeding follicular conjunctivitis due to influenza H1N1 virus. J Ophthalmol. 2010;2010:423672. https:\/\/doi.org\/10.1155\/2010\/423672.","journal-title":"J Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-01376-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-01376-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-01376-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T19:04:43Z","timestamp":1674932683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-01376-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":234,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1376"],"URL":"https:\/\/doi.org\/10.1038\/s41433-020-01376-y","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,29]]},"assertion":[{"value":"28 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}